Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 2/20 | 0.31 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.31 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.31 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 2/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL425248 | 0.89 | ALDH1A1 (0.41) | ALDH1A1LMNA | |
| SCHEMBL427083 | 0.88 | ALDH1A1 (0.44) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL429398 | 0.87 | ALDH1A1 (0.47) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL424041 | 0.86 | ALDH1A1 (0.42) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL426348 | 0.85 | ALDH1A1 (0.52) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL431227 | 0.84 | ALDH1A1 (0.47) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL15512286 | 0.83 | ALDH1A1 (0.43) | ALDH1A1ACLYLMNA | |
| SCHEMBL429385 | 0.83 | ALDH1A1 (0.43) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| Ethylene Glycol SCHEMBL423238 | 0.82 | ALDH1A1 (0.42) | ALDH1A1PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL423239 | 0.80 | ALDH1A1 (0.46) | ALDH1A1PRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120020906-A1 | ANTIPERSPIRANT SPRAYS WITH ESTER OILS | HENKEL AG & CO. KGAA (DE) | 2012-01-26 | — | — | US | claimed |
| US-20170157025-A1 | TEXTILE FRIENDLY ANTIPERSPIRANT COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2017-06-08 | — | — | US | disclosed |
| EP-2705879-B1 | COMBINATION OF OILS FOR ANTIPERSPIRANT COMPOSITIONS WITH IMPROVED WHITE MARK PROTECTION | HENKEL AG & CO KGAA (DE) | 2017-06-07 | — | — | EP | disclosed |
| EP-2480192-B1 | NON-AEROSOL WATER-FREE ANTIPERSPIRANT IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO KGAA (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-2480193-B1 | NON-AEROSOL WATER-FREE ANTIPERSPIRANT IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO KGAA (DE) | 2015-08-19 | — | — | EP | disclosed |
| US-8828367-B2 | Water-free antiperspirant non-aerosols in which active substances are more readily released | HENKEL AG & CO. KGAA (DE) | 2014-09-09 | — | — | US | disclosed |
| EP-2705879-A1 | COMBINATION OF OILS FOR ANTIPERSPIRANT COMPOSITIONS WITH IMPROVED WHITE MARK PROTECTION | Henkel AG&Co. KGAA (DE) | 2014-03-12 | — | — | EP | disclosed |
| US-8603445-B2 | Water-free antiperspirant sprays in which active substances are more readily released | HENKEL AG & CO. KGAA (DE) | 2013-12-10 | — | — | US | disclosed |
| US-20120177589-A1 | WATER-FREE ANTIPERSPIRANT NON-AEROSOLS IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO. KGAA (DE) | 2012-07-12 | — | — | US | disclosed |
| US-20120171143-A1 | WATER-FREE ANTIPERSPIRANT SPRAYS IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO. KGAA (DE) | 2012-07-05 | — | — | US | disclosed |
| US-20120020906-A1 | ANTIPERSPIRANT SPRAYS WITH ESTER OILS | HENKEL AG & CO. KGAA (DE) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020906-A1 | ANTIPERSPIRANT SPRAYS WITH ESTER OILS | CUTA, NAPEPLD, LIPE | ALDH1A1 1032/4885PRKCA 1624/4885PRKCE 608/4885 |
| US-20120177589-A1 | WATER-FREE ANTIPERSPIRANT NON-AEROSOLS IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | SIGMAR1, POLR1C, CUTA | ALDH1A1 2601/4885PRKCA 3518/4885PRKCE 1702/4885 |
| US-20120171143-A1 | WATER-FREE ANTIPERSPIRANT SPRAYS IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | POLR1C, CUTA, PHOSPHO1 | ALDH1A1 1827/4885PRKCA 3016/4885PRKCE 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.